Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions.
Ontology highlight
ABSTRACT: Chemical screens across hundreds of cell lines have shown that the drug sensitivities of human cancers can vary by genotype or lineage. However, most drug discovery studies have relied on culture media that poorly reflect metabolite levels in human blood. Here, we perform drug screens in traditional and Human Plasma-Like Medium (HPLM). Sets of compounds that show conditional anticancer activity span different phases of global development and include non-oncology drugs. Comparisons of the synthetic and serum-derived components that comprise typical media trace sets of conditional phenotypes to nucleotide synthesis substrates. We also characterize a unique dual mechanism for brivudine, a compound approved for antiviral use. Brivudine selectively impairs cell growth in low folate conditions b
SUBMITTER: Flickinger KM
PROVIDER: S-EPMC11451515 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA